Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

By CNBC
| February 12, 2024

Both companies are showing encouraging progress in their efforts to increase supply.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...